| scholarly article | Q13442814 |
| P2093 | author name string | Grandchamp B | |
| Peuchmaur M | |||
| Lemonnier F | |||
| Vilmer E | |||
| Garcia F | |||
| Duval M | |||
| Langlade-Demoyen P | |||
| Yotnda P | |||
| P2860 | cites work | Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation | Q24642901 |
| A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. | Q34147970 | ||
| Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation | Q34340175 | ||
| Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes | Q35093159 | ||
| Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice | Q35888374 | ||
| Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes | Q36363449 | ||
| Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein | Q36687045 | ||
| TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia. | Q36807501 | ||
| An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein | Q37644137 | ||
| High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. | Q38288856 | ||
| Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes | Q39733329 | ||
| Analysis of ETV6 and ETV6-AML1 proteins in acute lymphoblastic leukaemia | Q41101992 | ||
| BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes | Q41371291 | ||
| Constitutive expression of c-myc does not relieve cAMP-mediated growth arrest in human lymphoid Reh cells | Q41522106 | ||
| The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia | Q47335313 | ||
| Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules | Q55042699 | ||
| The involvement of transforming growth factor beta in the impaired antitumor T-cell response at the gut-associated lymphoid tissue (GALT) | Q70786892 | ||
| TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis | Q71020950 | ||
| Efficient binding to the MHC class I K(d) molecule of synthetic peptides in which the anchoring position 2 does not fit the consensus motif | Q71130344 | ||
| A simple assay for detection of peptides promoting the assembly of HLA class I molecules | Q72285904 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| cytotoxicity | Q246181 | ||
| P304 | page(s) | 455-462 | |
| P577 | publication date | 1998-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia | |
| P478 | volume | 102 |
| Q40608665 | A gene expressed exclusively in acute B lymphoblastic leukemias |
| Q36813562 | A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas. |
| Q47608571 | A structure-based approach for prediction of MHC-binding peptides |
| Q28184349 | AML1 interconnected pathways of leukemogenesis |
| Q35293385 | Absence of leukaemic fusion gene transcripts in preterm infants exposed to diagnostic x rays |
| Q34875170 | Adoptive cellular therapy: a therapeutic reality? |
| Q52953925 | Altered patterns of T cell cytokine production induced by relapsed pre-B ALL cells. |
| Q36240201 | Antigen-specific cellular immunotherapy of leukemia. |
| Q36662079 | Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation |
| Q72995666 | Augmentation of immune response by altered peptide ligands of the antigenic peptide in a human CD4+ T-cell clone reacting to TEL/AML1 fusion protein |
| Q24806130 | BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1 |
| Q78306894 | CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia |
| Q74169459 | Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination |
| Q34417562 | Exploiting genetic alterations to design novel therapies for cancer |
| Q34451905 | Gene therapy for paediatric leukaemia |
| Q46171835 | Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia |
| Q41533232 | Human Tumor Antigens and Cancer Immunotherapy |
| Q47133741 | Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients |
| Q34155839 | Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells. |
| Q40750584 | Identification of a novel WT1-derived peptide which induces human leucocyte antigen-A24-restricted anti-leukaemia cytotoxic T lymphocytes |
| Q36369960 | Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells |
| Q35169125 | Identification of human tumor antigens recognized by T-cells and their use for immunotherapy |
| Q46050360 | Immunity and protection, the unfolding of a tale |
| Q90215738 | Immunogenic neoantigens derived from gene fusions stimulate T cell responses |
| Q33731552 | Immunotherapy in acute leukemia |
| Q35971029 | Immunotherapy targets in pediatric cancer |
| Q37851050 | Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes |
| Q35994924 | Interferon alpha and T-cell responses in chronic myeloid leukemia |
| Q34214817 | Leukemia vaccines |
| Q78581871 | Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes |
| Q34060270 | MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1. |
| Q36891310 | Mobilizing the low-avidity T cell repertoire to kill tumors |
| Q89965697 | Neoantigens in Hematologic Malignancies |
| Q92539066 | Neoantigens in Hematological Malignancies-Ultimate Targets for Immunotherapy? |
| Q37248354 | Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease |
| Q57941422 | Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study |
| Q40661469 | Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study |
| Q34258082 | Prospect for immunotherapy of acute lymphoblastic leukemia |
| Q34608658 | T-cell therapy of leukemia. |
| Q33750862 | T-cell-based therapies for malignancy and infection in childhood |
| Q34108113 | Targeting pediatric malignancies for T cell-mediated immune responses |
| Q36745749 | Telomerase immunity from bench to bedside: round one. |
| Q36042528 | Telomerase reverse transcriptase as target for anti-tumor T cell responses in humans |
| Q92538890 | The Genomic Landscape of Antigenic Targets for T Cell-Based Leukemia Immunotherapy |
| Q99548643 | The Origin and Immune Recognition of Tumor-Specific Antigens |
| Q35000726 | The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research |
| Q59094157 | Transplantation for Childhood Acute Lymphoblastic Leukemia |
| Q35214398 | Tumor-associated antigens: from discovery to immunity |
| Q34399765 | Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy |
| Q64378949 | [Contribution of antineoplastic biotherapy in the treatment of leukemia in children] |
Search more.